Evidence map›Paper›PMID 26577378›Full record

ArticleRNA (New York, N.Y.)2016

Systematic study of cis-antisense miRNAs in animal species reveals miR-3661 to target PPP2CA in human cells.

Jian Wang, Zongcheng Li, Bailong Liu, Guangnan Chen, Ningsheng Shao, Xiaomin Ying, Ya Wang

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. In Silico Study of piRNA Interactions with the SARS-CoV-2 Genome.International journal of molecular sciences · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jian WangDepartment of Radiation Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA.
Zongcheng LiBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Bailong LiuDepartment of Radiation Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA The First Norman Bethune Hospital of Jilin University, Changchun 130012, China.
Guangnan ChenDepartment of Radiation Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA.
Ningsheng ShaoBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Xiaomin YingBeijing Institute of Basic Medical Sciences, Beijing 100850, China.
Ya WangDepartment of Radiation Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University, Atlanta, Georgia 30322, USA ywang94@emory.edu yingxm@bmi.ac.cn.
Emory University · USBeijing Institute of Education · CN

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Suresh S Ramalingam · 2009 to 2026
$47.5M
miR-21 signaling in tumor response to radiation treatmentR01CA186129 · NCI · EMORY UNIVERSITY · PI WANG, YA · 2014 to 2018
$1.6M
Mechanism for miR-21-modulated radioresistanceR21CA185882 · NCI · EMORY UNIVERSITY · PI WANG, YA · 2015 to 2016
$373k
NCI NIH HHS CA185882NCI NIH HHS CA186129NCI NIH HHS P30 CA138292NCI NIH HHS P30CA138292NCI NIH HHS R01 CA186129NCI NIH HHS R21 CA185882
6 · The paper itself

Abstract

MicroRNAs (miRNAs) suppress targeting gene expression through blocking translation or triggering mRNA degradation and, in general, act in trans, through a partially complementary interaction with the 3' untranslated region (3' UTR) or coding regions of a target gene. Although it has been reported previously that some miRNAs suppress their target genes on the opposite strand with a fully complementary sequence (i.e., natural antisense miRNAs that act in cis), there is no report to systematically study such cis-antisense miRNAs in different animal species. Here we report that cis-antisense miRNAs do exist in different animal species: 48 in Caenorhabditis elegans, 17 in Drosophila, 36 in Mus musculus, and 52 in Homo sapiens using a systematical bioinformatics approach. We show that most of these cis-antisense miRNAs can efficiently reduce the expression levels of their target genes in human cells. We further investigate hsa-miR-3661, one of the predicted cis-antisense miRNAs, in detail and demonstrate that this miRNA directly targets the coding sequence of PPP2CA located on the opposite DNA strand and inhibits the PPP2CA expression. Taken together, these results indicate that cis-antisense miRNAs are conservative and functional in animal species including humans.

Indexed as

AnimalsHumansMicroRNAsPhosphorylationProtein Phosphatase 2RNA, AntisenseSpecies SpecificityMicroRNAsProtein Phosphatase 2RNA, Antisensecis-antisensegene expressionhuman cellsmiR-3661miRNAPPP2CA

Identifiers

PMID26577378
PMCPMC4691837
OpenAlexW2176415571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.